Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2009
03/19/2009US20090075336 Variant Humicola Grisea CBH1.1
03/19/2009US20090075334 screening for a compound to change binding of ligand polypeptide for the orphan G protein-coupled receptor protein, APJ and a DNA encoding the same; drug screening; used in treating HIV infection, cancer, and various other diseases and disorders
03/19/2009US20090075332 Modified Proteases
03/19/2009US20090075327 Methods for improving secondary metabolite production in fungi
03/19/2009US20090075326 Reproductive ablation constructs
03/19/2009US20090075320 Method for screening an enhancer or a masker of salty taste
03/19/2009US20090075316 Alzheimer's Disease Secretase, APP Substrates Therefor and Uses Therefor
03/19/2009US20090075314 Using variation in arrestin/g-coupled protein receptor complex distribution as evaluative tool in identifying modulators for treatment of gastrointestinal and cell proliferative disorders
03/19/2009US20090075302 Compositions and methods for the diagnosis and treatment of tumor
03/19/2009US20090075297 Mammalian galanin receptors
03/19/2009US20090075294 Eukaryotic mechanosensory transduction channel
03/19/2009US20090075283 Vectors and Methods for Cloning Gene Clusters or Portions Thereof
03/19/2009US20090075281 Mtbe genes
03/19/2009US20090075279 Compositions and methods for the diagnosis and treatment of tumor
03/19/2009US20090075278 Compositions and methods for the diagnosis and treatment of tumor
03/19/2009US20090075270 Products and Methods Relating to the Use of the Endoribonuclease Kid/PemK
03/19/2009US20090075249 Transforming plant tissue with nucleotide sequences coding enzyme associated with fatty acid biosynthesis; for use in modifying plant oil characteristics, polyketide engineering and designing anticancer and antituberculosis agents
03/19/2009US20090074925 Enzymes
03/19/2009US20090074913 Gene Encoding Protein Responsible for Flocculation Property of Yeast and Use Thereof
03/19/2009US20090074870 Alteration of cell membrane for new functions
03/19/2009US20090074817 Type iii secretion pathway in aeromonas salmonicida, and uses therefor
03/19/2009US20090074814 DNA Vaccines Encoding Antigen Linked to a Domain That Binds CD40
03/19/2009US20090074810 Modified Adenovirus Hexon Protein and Uses Thereof
03/19/2009US20090074808 Secreted Streptococcus Pneumoniae Proteins
03/19/2009US20090074807 Moraxella (branhamella) catarrhalis antigens
03/19/2009US20090074806 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
03/19/2009US20090074804 Vero cell-based influenza virus strains and vaccines
03/19/2009US20090074801 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen phl p 7
03/19/2009US20090074799 Antibodies to class ii cytokine receptor-7
03/19/2009US20090074798 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
03/19/2009US20090074794 for use in the treatment of crohn's and ulcerative colitis; administering a composition comprising an effective amount of at least one isolated mammalian anti-tumor necrosis factor (TNF) antibody comprising at least one variable region comprising SEQ ID NO:7 and 8
03/19/2009US20090074793 High Affinity Human Antibodies to Human IL-4 Receptor
03/19/2009US20090074782 Compositions and Methods for Treating and Diagnosing Cancer
03/19/2009US20090074778 human monoclonal or polyclonal antibodies or fragments, that specifically binds to proteins in a blot analysis or enzyme-linked immunosorbent assay; detection of proteins in biological samples
03/19/2009US20090074776 relates to nucleic acid sequences encoding a member of the fibroblast growth factor (FGF) family, and to polypeptides encoded by the nucleic acid sequence
03/19/2009US20090074773 Cancer vaccine
03/19/2009US20090074770 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the pH, compounds comprising the same, and uses thereof
03/19/2009US20090074767 Isolated human phosphodiesterase proteins, nucleic acid molecules encoding human phosphodiesterase proteins, and uses thereof
03/19/2009US20090074742 Protein, osteoclast differentiation inhibitor, inflammatory bone resorption therapeutic agent, gene, recombinant vector, method of manufacturing a protein, method of inhibiting osteoclast differentiation, and method of treating inflammatory bone resorption
03/19/2009US20090074741 Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response
03/19/2009US20090074733 Thymidylate kinase mutants and uses thereof
03/19/2009US20090074726 Mva expressing modified hiv envelope, gag, and pol genes
03/19/2009US20090074723 Method of Treating or Retarding the Development of Blindness
03/19/2009US20090074722 Products and methods for treating PTP lar diseases
03/19/2009US20090074680 Statherin peptide and use in medicine
03/19/2009US20090074669 PNMT as a novel marker for progenitor cells
03/19/2009US20090074665 Diagnosis and treatment of cancer:I
03/19/2009US20090074663 Peptide for diagnosing, preventing and treating atherosclerosis and uses thereof
03/19/2009US20090074660 Human Monoclonal Antibodies To O8E
03/19/2009US20090074658 Compositions and methods for generating and screening adenoviral libraries
03/19/2009US20090074657 Nucleotide and protein sequences of an antibody directed against an epitope common to human acidic and basic ferritins, monoclonal antibodies or antibody-like molecules comprising these sequences and uses thereof
03/19/2009DE102007045092A1 Enzymsystem mit der Aktivität einer Monooxygenase und Verfahren zur Oxidation von Methylgruppen in aliphatischen Kohlenwasserstoffen Enzyme with the activity of a monooxygenase system and process for the oxidation of methyl groups in aliphatic hydrocarbons
03/19/2009DE102007044415A1 Leistungsverbesserte Proteasen und Wasch- und Reinigungsmittel enthaltend diese Proteasen Performance enhanced proteases and detergents and cleaning agents containing these proteases
03/19/2009DE102007044134A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von verbesserten Stämmen der Familie Enterobacteriaceae A process for the preparation of L-amino acids using strains of the Enterobacteriaceae family improved
03/19/2009DE102007041862A1 Mikrobiologische Herstellung von Isoprenoiden Microbiological production of isoprenoids
03/19/2009CA2704725A1 Increased alpha-prime beta-conglycinin soybeans
03/19/2009CA2699813A1 Phase ii detoxification and antioxidant activity
03/19/2009CA2699646A1 Mirna expression in human peripheral blood microvesicles and uses thereof
03/19/2009CA2699547A1 Two step cluster deletion and humanisation
03/19/2009CA2699465A1 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use
03/19/2009CA2699429A1 Recombinant preparation of selected bromelain fractions
03/19/2009CA2699370A1 Compositions and methods for the identification of inhibitors of retroviral infection
03/19/2009CA2699201A1 Trichoderma promoter
03/19/2009CA2699150A1 Plasmids from thermophilic organisms, vectors derived therefrom, and uses thereof
03/19/2009CA2699093A1 Malva mosaic virus and virus-like particles and uses thereof
03/19/2009CA2699066A1 Plants having increased yield-related traits and a method for making the same
03/19/2009CA2698990A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects
03/19/2009CA2698989A1 Plants which synthesize increased amounts of glucosaminoglycans
03/19/2009CA2698972A1 Regulatory elements associated with cbf transcription factors from maize
03/19/2009CA2698801A1 Molecule production by photosynthetic organisms
03/19/2009CA2698400A1 Method and composition for cancer diagnosis and treatment
03/19/2009CA2697193A1 Rationally designed, synthetic antibody libraries and uses therefor
03/19/2009CA2696987A1 Hepatitis b pre-s2 nucleic acid
03/19/2009CA2696963A1 Compositions and methods for preventing influenza infection in canines, felines and equines
03/18/2009EP2037271A1 Methods using O6-alkylguanine-DNA alkyltransferases
03/18/2009EP2036991A1 Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay
03/18/2009EP2036986A1 Continuous assay method for measuring receptor- and ion channel-mediated calcium response and subsequent gene expression
03/18/2009EP2036985A1 Antibody gene transfer and recombinant AAV therefor
03/18/2009EP2036984A2 Reversion of the negative selective effect of negative marker proteins as selection procedure
03/18/2009EP2036983A1 Plants synthesizing increased amounts of glucosaminglycans
03/18/2009EP2036982A1 Pesticidal proteins
03/18/2009EP2036981A1 Aptamers labeled with 18F
03/18/2009EP2036980A1 Down regulation of gene expression using virus-like particles charged with nucleic acid
03/18/2009EP2036978A1 Recombinant preparation of selected bromelain fractions
03/18/2009EP2036926A2 Single-chain, multiple antigen forming molecule, its manufacture and use
03/18/2009EP2036925A1 Novel steroid-activated nuclear receptors and uses therefor
03/18/2009EP2036635A1 Metal particle, magnetic bead for biological substance extraction, and their production methods
03/18/2009EP2036584A1 Substrate for biological fluid treatment
03/18/2009EP2035828A1 Methods and tools for the screening of factors affecting protein misfolding
03/18/2009EP2035569A1 A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family with attenuated expression of the rcsa gene
03/18/2009EP2035566A2 Materials and complexes for the delivery of biologically-active material to cells
03/18/2009EP2035564A2 Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells
03/18/2009EP2035563A2 Pathogen-inducible synthetic promoter
03/18/2009EP2035562A2 Plants with modulated expression of extensin receptor-like kinase having enhanced yield-related traits and a method for making the same
03/18/2009EP2035561A1 A method for achieving improved polypeptide expression
03/18/2009EP2035560A2 Delta-5 desaturase and its use in making polyunsaturated fatty acids
03/18/2009EP2035559A2 Methods and compositions related to bacterial flagellum and nanotube formation
03/18/2009EP2035558A2 Dna fragmentation assay
03/18/2009EP2035555A2 Plants having improved growth characteristics and method for making the same
03/18/2009EP2035553A1 Lysophosphatidic acid acyltransferase genes and uses thereof